ARS Pharmaceuticals, Inc.(NasdaqGM:SPRY) dropped from Russell 2000 Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.11 USD | +6.21% |
|
+22.22% | +102.74% |
Jul. 11 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
Jul. 11 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+102.74% | 1.08B | |
+23.50% | 47.07B | |
+47.19% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |
- Stock Market
- Equities
- SPRY Stock
- News ARS Pharmaceuticals, Inc.
- ARS Pharmaceuticals, Inc.(NasdaqGM: SPRY) dropped from Russell 2000 Value Index